期刊文献+

影响肝移植术后新发糖尿病逆转的相关因素 被引量:3

Related factors associated with reversal of new-onset diabetes mellitus following liver transplantation
原文传递
导出
摘要 目的探讨影响肝移植术后新发糖尿病(PTDM)逆转的相关因素。方法回顾分析232例肝移植受者的临床资料,术后共有62例患者发生PTDM,发生率为26.7%。根据PTDM是否发生逆转,将62例患者分为暂时性PTDM组(34例)和持续性PTDM组(28例)。对两组患者的性别、年龄、体重指数、糖尿病家族史、乙型肝炎病毒感染情况、术前空腹血糖水平、免疫抑制剂使用及其血药浓度、皮质激素的使用时间等相关因素进行分析。结果两组间患者的性别、体重指数、糖尿病家族史、术前空腹血糖水平、免疫抑制方案中皮质激素的持续使用时间、术后血他克莫司浓度及使用环孢素A的患者比例等因素的差异均无统计学意义(P〉0.05)。与持续性PTDM组相比,暂时性PTDM组患者移植时年龄较轻,分别为(54±8)岁和(42±6)岁(P〈0.05);发生PTDM的术后时问较晚,分别为术后(18±23)d和(35±42)d(P〈0.05);免疫抑制方案中联合运用吗替麦考酚酯(MMF)或西罗莫司(SRL)的患者比例较高,分别为0和8.9%(P〈0.05)。经多因素Logistic回归分析显示,只有移植时年龄是PTDM逆转的独立预测因子(比值比为1.312,95%可信区间为1.005~1.743)。结论患者移植时年龄、发生PTDM时的术后时间及免疫抑制方案中使用MMF或SRL的患者比例等因素与肝移植术后PTDM逆转相关,但只有移植时年龄是PTDM逆转的独立预测因子。 Objective To study the related factors associated with the reversal of posttransplant diabetes mellitus (PTDM) following liver transplantation. Methods The clinical data of 62 patients with PTDM in 232 patients receiving liver transplantation (26. 7 % ) were retrospectively analyzed and the patients were divided into two groups: patients with transient PTDM (34 cases) and those with persistent PTDM (28 cases). Pre-operative and post-operative variables, including sex, age, body mass index, family history of diabetes, hepatitis B virus infection, pretransplantation fasting plasma glucose, the immunosuppressant regime, FK506 concentration and duration of steroid usage, were analyzed retrospectively. Results The variables, including sex, age, body mass index, family history of diabetes, hepatitis B virus infection, pretransplantation fasting plasma glucose, FK506 concentration at month 1, 3 and 6 after operation, rate of cyclosporine usage and duration of steroid usage had no significant difference between the two groups (P〉0. 05). Compared with the persistent PTDM patients, the transient PTDM patients were characterized by younger age at the time of transplantation (54 ± 8 vs. 42 ± 6 years, P〈0. 05), longer time before the development of PTDM (18 ± 23 vs. 35 ± 42 days, P〈0. 05), and higher rate of mycophenolate mofetil or sirolimus usage (0 vs. 8. 9 %, P〈 0. 05). Based on a multivariate analysis, age at the time of transplantation was determined as the single independent predictive factor associated with reversal of PTDM following liver transplantation (odds ratio: 1. 312, 95 % confidence interval.. 1. 005 - 1. 743). Conclusion Age at the time of transplantation, duration before the development of PTDM and rate of mycophenolate mofetil or sirolimus usage are associated with reversal of PTDM following liver transplantation. Among these factors, age at the time of transplantation is only the single independent predictive factor.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2011年第4期221-223,共3页 Chinese Journal of Organ Transplantation
基金 国家重点基础研究发展计划项目(973分课题)(2009CB522404) 十一五科技攻关项目(2008ZX10002-025) 广东省科技计划项目重大专项(2007A032000001) 教育部新教师基金(20100171120084,20100171120087)
关键词 肝移植 糖尿病 逆转 危险因素 vLiver transplantation Diabetes mellitus Reversibility Risk factors
  • 相关文献

参考文献8

  • 1Moon JI,Barbeito R,Faradji RN,et al.Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation:Long-term follow up.Transplantation,2006,82(12):1625-1628.
  • 2Atn HY,Cho YM,Yi NJ,et al.Predictive factors associated with the reversibility of post-transplantation diabetes mellitus following liver transplantation.J Korean Med Sci,2009,24(4):567-570.
  • 3Perkins JD.Reversibility of posttransplantation diabetes mellitus following liver transplantation.Liver Transpl,2009,15(11):1631-1632.
  • 4Davidson J,Wilkinson A,Dantal J,et al.New-onset diabetes after transplantation:2003 International consensus guidelines.Proceedings of an international expert panel meeting.Barcelona,Spain,19 February 2003.Transplantation,2003,75(Suppl 10):S23-24.
  • 5Saliba F,Lakehal M,Pageaux GP,et al.Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection:an observational multicenter study.Liver Transpl,2007,13 (1):136-144.
  • 6吴亚夫,施晓雷,仇毓东,江春平,吴星宇,李强,丁义涛.肝移植术后糖尿病危险因素分析[J].中华器官移植杂志,2006,27(6):366-368. 被引量:6
  • 7Masini M,Campani D,Boggi U,et al.Hepatitis C virus infection and human pancreatic beta-cell dysfunction.Diabetes Care,2005,28(4):940-941.
  • 8Hur KY,Kim MS,Kim YS,et al.Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients.Diabetes Care,2007,30(3):609-615.

二级参考文献11

  • 1Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation,2003, 76: 1320-1326.
  • 2Tueche SG. Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding. Transplant Proc,2003, 35: 1466-1468.
  • 3Panz VR, Bonegio R, Raal FJ, et al. Diabetogenic effect of tacrolimus in South African patients undergoingkidney transplantation. Transplantation, 2002, 73: 587-590.
  • 4Kruszynska YT, Home PD, Mcintyre N. Relationship between Insulin sensitivity and Glucose Tolerance in cirrhosis. Hepatology, 1991, 14: 103-111.
  • 5Varo E, Padin E, Otero S, et al. Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. Transplant Proc, 2002, 34: 1553-1554.
  • 6Hirano Y, Fujihara S, Ohara K, et al. Morphological and functional changes in islets of Langerhans in FK506-treated rats.Transplantation, 1992, 53: 889.
  • 7Redom JB, Olson LK, Armstrong MB, et al, Effects of trcrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T 15 cells. J Clin Invest,1996, 98: 2786-2793.
  • 8Konrad T, Steinmuller T, Vicini P, et al. Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. Transplantation, 2000, 69:2072-2078.
  • 9Stegall MD, Everson G, Schooter G, et al. Metabolic xomplication after liver transplantation. Transplantation, 1995, 60:1057-1060.
  • 10Mcmahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev, 1988, 4: 17-19.

共引文献5

同被引文献14

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部